chevron_leftBack
As of 16 June 2026, Bioinfra Life Science, Inc. has a market cap of $2.48M USD, ranking #46705 globally and #2759 in South Korea.
It ranks #4134 in the Healthcare sector, and #872 in the Medical Devices industry.
Key Stats
Market Cap
$2.48MUSD
3.76B KRW
Company Profile
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -15% | -40% | 14% | -12% | -50% | -54% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
266470
(주)바이오인프라생명과학
ISIN: KR7266470004
Shares Out.:
Shares Outstanding:
27.866M1
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
115 KRW |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
KRX: 214150
|
$2.47B
100K%
3.75T KRW
|
28.7
|
|
KRX: 458870
|
$1.23B
49K%
1.86T KRW
|
114.8
|
|
KRX: 491000
|
$1.19B
48K%
1.81T KRW
|
-
|
|
KRX: 290650
|
$1.14B
46K%
1.74T KRW
|
-
|
|
KRX: 096530
|
$760.97M
31K%
1.16T KRW
|
23.9
|
|
KRX: 214430
|
$533.35M
21K%
809.64B KRW
|
83.3
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: TMO
|
$173.27B
7M%
|
25.8
|
|
NASDAQ: ISRG
|
$160.73B
6M%
|
56.7
|
|
NYSE: ABT
|
$159.07B
6M%
|
25.6
|
|
NYSE: DHR
|
$126.55B
5M%
|
34.7
|
|
NYSE: SYK
|
$120.69B
5M%
|
38.3
|
|
NYSE: MDT
|
$101.9B
4M%
|
22.2
|
chevron_leftBack